Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy

American Journal of Health-System Pharmacy · Published 2026-07-03 · DOI 10.1093/ajhp/zxag202

Authors (4)

Michael P Gulseth, Corey Dinunno, Marc D Smith, Maureen A Smythe

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gulseth, M., Dinunno, C., Smith, M., et al. (2026). Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag202

Related articles

• Creating a framework for delivering digital and telehealth knowledge to future and current pharmacists · American Journal of Health-System Pharmacy · 2026 · Same journal
• Beyond alert fatigue: Automation bias, deskilling, and clinical decision-making in the age of AI · American Journal of Health-System Pharmacy · 2026 · Same journal
• Pharmacists versus artificial intelligence: Bridging the clinical evidence gap · American Journal of Health-System Pharmacy · 2026 · Same journal
• Generative artificial intelligence tools as an aid for pharmacy career preparation · American Journal of Health-System Pharmacy · 2026 · Same journal
• Implementation and evaluation of an investigational drug service–led approach for concomitant medication reviews in clinical trials · American Journal of Health-System Pharmacy · 2026 · Same journal
• Cefazolin for all or just some? A review of cefazolin for surgical site infection prophylaxis in patients with β-lactam allergies · American Journal of Health-System Pharmacy · 2026 · Same journal
• Impact of nasogastric administration using the simple suspension method on serum tirabrutinib levels: A case report · American Journal of Health-System Pharmacy · 2026 · Same journal
• The impact of a multidisciplinary team on adherence to recommended antimicrobial therapy in neurosurgical units in Thailand · American Journal of Health-System Pharmacy · 2026 · Same journal
• Tebipenem pivoxil · American Journal of Health-System Pharmacy · 2026 · Same journal
• Lunsotogene Parvec-cwha · American Journal of Health-System Pharmacy · 2026 · Same journal